What is the address of AB THERAPY?

The registered office of AB THERAPY is located at Jean Jacquetstraat 7, 1081 Koekelberg.

Is AB THERAPY still active?

Yes. According to the CBE (30 September 2026) AB THERAPY is active, legal situation “Normale toestand”, started on 6 November 2020.

Is AB THERAPY registered on Peppol?

Yes, AB THERAPY is registered on the Peppol network with ID 0208:0757880893.

What is the enterprise number of AB THERAPY?

The enterprise number of AB THERAPY is BE0757880893.

When was AB THERAPY founded?

AB THERAPY was founded on 6 November 2020.

Who are the directors of AB THERAPY?

According to the 2025 annual accounts, the directors of AB THERAPY are: Ayoub BOULAHRIR.

Is AB THERAPY a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 6 November 2020; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did AB THERAPY make in 2025?

AB THERAPY posted a profit after taxes of € 26,173 in financial year 2025.

What is the revenue of AB THERAPY?

As a small company, AB THERAPY is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 43,880.

AB THERAPY (Private Limited) - Koekelberg - BE0757880893

Dossier AB THERAPY, printed on 30 September 2026 from databakkes.be/en/0757880893/ab-therapy. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

AB THERAPY from Koekelberg, company number BE0757880893, closed financial year 2025 with a result of € 26,173 after tax. For that financial year AB THERAPY recorded a gross margin of € 43,880 and equity of € 67,622. Compared with financial year 2024, the result moved from € 37,136 to € 26,173. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 23, 2026.

What it is worth Healthy

€ 67,622

▼ 14% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 26,173

▼ 30% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 58,021

▲ 72% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 37,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Wage cost estimate Staff cost at a one-person company Staff Only people on the payroll count here.€ 2,112 Likely the director’s social contribution or pension premium.The director’s pay Already netted into the gross margin, not shown separately in the accounts. Typical for one-person companies € 45,000 gross per year minimum for the reduced tax rate≈ € 2,100 net per month after contributions, tax and usually some benefits in kind, roughly Assumption based on the chart of accounts, not a figure from the source.

€ 2,112

▲ 71% vs 2024

No payroll staff. An amount this small is usually a social contribution or pension premium for the director, booked under staff costs.

Vehicles and equipment

€ 8,012

▲ 68% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Taxes

€ 5,550

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 15,964 Gross margin 2022: € 15,964 First fiscal year in the series	€ 20,872 Gross margin 2023: € 20,872 ▲ 31% vs 2022 (€ 15,964) Favourable step	€ 47,971 Gross margin 2024: € 47,971 ▲ 130% vs 2023 (€ 20,872) Favourable step	€ 43,880 Gross margin 2025: € 43,880 ▼ 9% vs 2024 (€ 47,971) Unfavourable step	▼ 9%
Profit after taxes	€ 8,399 Profit after taxes 2022: € 8,399 First fiscal year in the series	€ 11,606 Profit after taxes 2023: € 11,606 ▲ 38% vs 2022 (€ 8,399) Favourable step	€ 37,136 Profit after taxes 2024: € 37,136 ▲ 220% vs 2023 (€ 11,606) Favourable step	€ 26,173 Profit after taxes 2025: € 26,173 ▼ 30% vs 2024 (€ 37,136) Unfavourable step	▼ 30%
Equity	€ 29,706 Equity 2022: € 29,706 First fiscal year in the series	€ 41,312 Equity 2023: € 41,312 ▲ 39% vs 2022 (€ 29,706) Favourable step	€ 78,448 Equity 2024: € 78,448 ▲ 90% vs 2023 (€ 41,312) Favourable step	€ 67,622 Equity 2025: € 67,622 ▼ 14% vs 2024 (€ 78,448) Unfavourable step	▼ 14%
Total debts	€ 51,415 Total debts 2022: € 51,415 First fiscal year in the series	€ 53,890 Total debts 2023: € 53,890 ▲ 5% vs 2022 (€ 51,415) Unfavourable step	€ 1,567 Total debts 2024: € 1,567 ▼ 97% vs 2023 (€ 53,890) Favourable step	€ 38,725 Total debts 2025: € 38,725 ▲ € 37,158 vs 2024 (€ 1,567) Unfavourable step	▲ € 37,158
Cash	€ 48,207 Cash 2022: € 48,207 First fiscal year in the series	€ 67,128 Cash 2023: € 67,128 ▲ 39% vs 2022 (€ 48,207) Favourable step	€ 33,766 Cash 2024: € 33,766 ▼ 50% vs 2023 (€ 67,128) Unfavourable step	€ 58,021 Cash 2025: € 58,021 ▲ 72% vs 2024 (€ 33,766) Favourable step	▲ 72%
Retained profit	€ 26,706 Retained profit 2022: € 26,706 First fiscal year in the series	€ 38,312 Retained profit 2023: € 38,312 ▲ 43% vs 2022 (€ 26,706) Favourable step	€ 75,448 Retained profit 2024: € 75,448 ▲ 97% vs 2023 (€ 38,312) Favourable step	€ 64,622 Retained profit 2025: € 64,622 ▼ 14% vs 2024 (€ 75,448) Unfavourable step	▼ 14%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 37,000 Dividend 2025: € 37,000 Unchanged (€ 0) Unchanged
Balance sheet total	€ 81,121 Balance sheet total 2022: € 81,121 First fiscal year in the series	€ 95,202 Balance sheet total 2023: € 95,202 ▲ 17% vs 2022 (€ 81,121) Unchanged	€ 80,015 Balance sheet total 2024: € 80,015 ▼ 16% vs 2023 (€ 95,202) Unchanged	€ 106,347 Balance sheet total 2025: € 106,347 ▲ 33% vs 2024 (€ 80,015) Unchanged	▲ 33%

Key figures of AB THERAPY, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to AB THERAPY?

What happened at AB THERAPY in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 23, 2026 New annual accounts for financial year 2025: profit of € 26,173 (▼ 30% vs 2024). Source: NBB ↗
Nov 6, 2020 New establishment in Koekelberg. KBO
Nov 6, 2020 Start of the company according to the CBE. KBO

In short

From € 8,399 profit in 2022 to € 26,173 profit in 2025.

Paid € 17,330 in corporate taxes since 2022.

Best year ever: 2024, with € 37,136 profit.

Paid out € 37,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at AB THERAPY? We notify you, reason included.

Follow AB THERAPY

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Ayoub BOULAHRIR

AB THERAPY

Behind AB THERAPY is Ayoub BOULAHRIR.

See the full network in the app

Directors

According to the 2025 annual accounts

Ayoub BOULAHRIR

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Jean Jacquetstraat 7

1081 Koekelberg

2.309.833.284

Jean Jacquetstraat 7 box 1

1081 Koekelberg

Active since 6 November 2020

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Association des copropriétaires rue Jean Jacquet, 7 à Koekelberg

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0757.880.893
VAT number: BE 0757.880.893
Registered office: Jean Jacquetstraat 7, 1081 Koekelberg
Names & denominations: AB THERAPY
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 6 November 2020
Peppol: Active · Active since 15 Dec 2025
Contact: [email protected]

View on CBE Public ↗ Annual accounts (NBB) ↗